Page 54 - AN-2-3
P. 54

Advanced Neurology                                                        TRPM7 signaling in glioblastoma



            Consent for publication                               is required for breast tumor cell metastasis.  Cancer Res,
                                                                  72: 4250–4261.
            Not applicable.
                                                                  https://doi.org/10.1158/0008-5472.can-11-3863
            Availability of data                               11.  Chen JP, Luan Y, You CX,  et al., 2010, TRPM7 regulates

            The data that support the findings of this study are available   the migration of human nasopharyngeal carcinoma cell by
            from the corresponding author upon reasonable request.  mediating Ca(2+) influx. Cell Calcium, 47: 425–432.
                                                                  https://doi.org/10.1016/j.ceca.2010.03.003
            References
                                                               12.  Ostrom  QT,  Gittleman  H, Fulop  J,  et al.,  2015,  CBTRUS
            1.   Nadezhdin KD, Correia L, Narangoda C,  et al., 2023,   statistical Report: Primary brain and central nervous system
               Structural mechanisms of TRPM7 activation and inhibition.   tumors diagnosed in the United States in 2008-2012. Neuro
               Nat Commun, 14: 2639.                              Oncol, 17: iv1–iv62.
               https://doi.org/10.1038/s41467-023-38362-3         https://doi.org/10.1093/neuonc/nov189
            2.   Nadler MJ, Hermosura MC, Inabe K, et al., 2001, LTRPC7   13.  Stupp R, Mason WP, van den Bent MJ,  et al., 2005,
               is a Mg.ATP-regulated divalent cation channel required for   Radiotherapy plus concomitant and adjuvant temozolomide
               cell viability. Nature, 411: 590–595.              for glioblastoma. N Engl J Med, 352: 987–996.
               https://doi.org/10.1038/35079092                   https://doi.org/10.1056/nejmoa043330
            3.   Monteilh-Zoller MK, Hermosura MC, Nadler MJS, et  al.,   14.  Wu W, Klockow JL, Zhang M,  et al., 2021, Glioblastoma
               2003,  TRPM7  provides  an  ion  channel  mechanism  for   multiforme (GBM): An overview of current therapies and
               cellular entry of trace metal ions. J Gen Physiol, 121: 49–60.   mechanisms of resistance. Pharmacol Res, 171: 105780.
               https://doi.org/10.1085/jgp.20028740               https://doi.org/10.1016/j.phrs.2021.105780
            4.   Krapivinsky G, Krapivinsky L, Manasian Y,  et al., 2014,   15.  Wong R, Gong H, Alanazi R,  et al., 2020, Inhibition of
               The TRPM7 chanzyme is cleaved to release a chromatin-  TRPM7 with waixenicin A reduces glioblastoma cellular
               modifying kinase. Cell, 157: 1061–1072.            functions. Cell Calcium, 92: 102307.
               https://doi.org/10.1016/j.cell.2014.03.046         https://doi.org/10.1016/j.ceca.2020.102307
            5.   Runnels  LW,  Yue  L,  Clapham  DE,  2001,  TRP-PLIK,  a   16.  Chen WL, Barszczyk A, Turlova E, et al., 2015, Inhibition
               bifunctional protein with kinase and ion channel activities.   of TRPM7 by carvacrol suppresses glioblastoma cell
               Science, 291: 1043–1047.                           proliferation, migration and invasion.  Oncotarget, 6: 
                                                                  16321–16340.
               https://doi.org/10.1126/science.1058519
                                                                  https://doi.org/10.18632/oncotarget.3872
            6.   Demeuse P, Penner R, Fleig A, 2006, TRPM7 channel is
               regulated by magnesium nucleotides via its kinase domain.   17.  Chen WL, Turlova E, Sun CLF,  et al., 2015, Xyloketal B
               J Gen Physiol, 127: 421–434.                       suppresses glioblastoma cell proliferation and migration
                                                                  in vitro through inhibiting TRPM7-regulated PI3K/Akt and
               https://doi.org/10.1085/jgp.200509410
                                                                  MEK/ERK signaling pathways. Mar Drugs, 13: 2505–2525.
            7.   Ji D, Fleig A, Horgen FD, et al., 2022, Modulators of TRPM7
               and its potential as a drug target for brain tumours.  Cell      https://doi.org/10.3390/md13042505
               Calcium, 101: 102521.                           18.  Leng TD, Li MH, Shen JF, et al., 2015, Suppression of TRPM7
                                                                  inhibits proliferation, migration, and invasion of malignant
               https://doi.org/10.1016/j.ceca.2021.102521
                                                                  human glioma cells. CNS Neurosci Ther, 21: 252–261.
            8.   Cao R, Meng Z, Liu T,  et al., 2016, Decreased TRPM7
               inhibits activities and induces apoptosis of bladder cancer      https://doi.org/10.1111/cns.12354
               cells via ERK1/2 pathway. Oncotarget, 7: 72941–72960.   19.  Liu M, Inoue K, Leng T,  et al., 2014, TRPM7 channels
                                                                  regulate glioma stem cell through STAT3 and Notch
               https://doi.org/10.18632/oncotarget.12146
                                                                  signaling pathways. Cell Signal, 26: 2773–2781.
            9.   Huang J, Furuya H, Faouzi M,  et al., 2017, Inhibition
               of TRPM7 suppresses cell proliferation of colon      https://doi.org/10.1016/j.cellsig.2014.08.020
               adenocarcinoma  in vitro and induces hypomagnesemia   20.  Wong R, Turlova E, Feng ZP,  et al., 2017, Activation of
               in vivo without affecting azoxymethane-induced early colon   TRPM7 by naltriben enhances migration and invasion of
               cancer in mice. Cell Commun Signal, 15: 30.        glioblastoma cells. Oncotarget, 8: 11239–11248.
               https://doi.org/10.1186/s12964-017-0187-9          https://doi.org/10.18632/oncotarget.14496
            10.  Middelbeek J, Kuipers AJ, Henneman L, et al., 2012, TRPM7   21.  Tian Y, Yang T, Yu S, et al., 2018, Prostaglandin E2 increases


            Volume 2 Issue 3 (2023)                         9                          https://doi.org/10.36922/an.334
   49   50   51   52   53   54   55   56   57   58   59